ToplineShares of telehealth company Hims & Hers Health closed at a three-year high Monday after the company announced a weight-loss treatment starting at $199 a month that will compete with Novo Nordisk’s Wegovy and Ozempic and enter the weight-loss market amid a shortage of branded treatments.Hims announced the treatment Monday. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket ... [+] via Getty Images)SOPA Images/LightRocket via Getty Images Key FactsHims shares closed up more than 27% at $18 ...